Ola Adel Novartis

Ola Adel

Ola Adel Novartis Site Quality Head Aseptics and Cell and Gene Therapy

Ola Adel, Site Quality Head of Aseptics and Cell and Gene therapy @Novartis Stein in Switzerland, Over 22 years of experience in the pharmaceutical field. Strategic and enterpriseminded quality leader with deep GxP expertise and a strong record of elevating operational and regulatory performance who brings together over 22 years of experience in the pharmaceutical field. Recognized for sound judgement, resilience and clarity in complex, highstakes environments. Influences senior stakeholders, drives crossfunctional alignment and builds highperforming, globally connected teams. Known for integrity, transparency and a strong patientcentered mindset. Contributed at Global Quality leadership level through strategic vision, systemlevel thinking and a proven ability to lead transformation across sites and functions.